SCHEMBL5822189

SCHEMBL5822189

C=CCc1c[c]ccc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 7/20 0.50
GABRB2 P47870 7/20 0.50
POLB P06746 2/20 0.43
CNR2 P34972 3/20 0.40
ALOX5 P09917 3/20 0.40
MEN1 O00255 2/20 0.40
GAA P10253 2/20 0.40
MAPT P10636 2/20 0.40
CNR1 P21554 2/20 0.40
KMT2A Q03164 2/20 0.40
GABRB1 P18505 1/20 0.40
RXRA P19793 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
ACE2 Q9BYF1 1/20 0.40
SIRT3 Q9NTG7 1/20 0.40
AKR1B1 P15121 2/20 0.39
XDH P47989 2/20 0.38
ALDH1A1 P00352 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2536793 0.81 GABRA1 (0.36) GABRA1GABRB2POLB
SCHEMBL20919835 0.77 HTT (0.47) ALOX5MEN1KMT2AAKR1B1XDH
SCHEMBL28452080 0.77 ALDH1A1 (0.32) ALDH1A1CYP3A4
SCHEMBL6594676 0.76 GABRA1 (0.33) GABRA1GABRB2
SCHEMBL7051562 0.76 GABRA1 (0.33) GABRA1GABRB2MEN1MAPTKMT2A
SCHEMBL4551210 0.75 GABRA1 (0.42) GABRA1GABRB2POLBCNR2ALOX5
SCHEMBL299309 0.74 GABRA1 (0.47) GABRA1GABRB2POLBCNR2ALOX5
SCHEMBL674550 0.74
SCHEMBL3644895 0.73 GABRA1 (0.32) GABRA1GABRB2
SCHEMBL930329 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2023-03-23 US claimed
WO-2021158573-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2021-08-12 WO claimed
WO-2021158575-A1 COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2021-08-12 WO claimed
CN-105315467-B Polymer having organosilicon structure, negative resist composition, photocurable dry film, and patterning method 信越化学工业株式会社 2019-12-20 CN claimed
CN-105315467-A Silicone structure-bearing polymer, negative resist composition, photo-curable dry film, and patterning process SHINETSU CHEMICAL CO 2016-02-10 CN claimed
CN-105256660-A Invisible-pattern anti-counterfeit paper HENAN JIANGHE PAPER CO LTD 2016-01-20 CN claimed
EP-0624166-A1 POLYMERIZABLE CARBOHYDRATE ESTERS, POLYMERS MADE FROM SUCH ESTERS AND THE USE OF SUCH POLYMERS. CIBA GEIGY AG (CH) 1994-11-17 EP claimed
WO-1994012540-A1 POLYMERIZABLE CARBOHYDRATE ESTERS, POLYMERS MADE FROM SUCH ESTERS AND THE USE OF SUCH POLYMERS CIBA-GEIGY AG (CH) 1994-06-09 WO claimed
US-5051460-A Chlorotrifluoroethylene-ethylene copolymer with heat resistant stabilizers, epoxy resins, phosphites and esters AUSIMONT, U.S.A., INC. (US) 1991-09-24 US claimed
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2023-03-23 US disclosed
WO-2021158575-A1 COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2021-08-12 WO disclosed
WO-2021158573-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES Natural Extraction Systems, LLC (US) 2021-08-12 WO disclosed
CN-105315467-B Polymer having organosilicon structure, negative resist composition, photocurable dry film, and patterning method 信越化学工业株式会社 2019-12-20 CN disclosed
CN-105541591-A 1-(4-hydroxy-3-aryl phenyl)-2-acetone and preparation method and application thereof UNIV HUNAN 2016-05-04 CN disclosed
EP-0683204-A2 Compositions based on ethylene/chlorotrifluoroethylene copolymers having high thermal stability AUSIMONT U.S.A. Inc. (US) 1995-11-22 EP disclosed
US-5051460-A Chlorotrifluoroethylene-ethylene copolymer with heat resistant stabilizers, epoxy resins, phosphites and esters AUSIMONT, U.S.A., INC. (US) 1991-09-24 US disclosed
US-5051460-A Chlorotrifluoroethylene-ethylene copolymer with heat resistant stabilizers, epoxy resins, phosphites and esters AUSIMONT, U.S.A., INC. (US) 1991-09-24 US disclosed
US-4981934-A Curable composition comprising bis-imide and bis-(alkenyl phenol) TECHNOCHEMIE GMBH VERFAHRENSTECHNIK (DE) 1991-01-01 US disclosed
EP-0355926-A2 Alkenyl-modified polyimides Technochemie GmbH - Verfahrenstechnik (DE) 1990-02-28 EP disclosed
US-4713475-A HEAT AND OXIDATION RESISTANCE CIBA-GEIGY CORPORATION (US) 1987-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230089351-A1 METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES FABP2, FABP4, GUSB GABRA1 4231/4885GABRB2 2535/4885POLB 2461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.